Metraipolis › archive › dc_aff86af1d84f

Rituximab monotherapy versus glucocorticoid therapy for adult minimal change disease: a retrospective study on noninferiority — Europe PMC PMID:41446027

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41446027
DOI
10.3389/fneph.2025.1715546
License (as archived)
solo-consultazione
Archived
2026-11-07T18:40:35.667Z
SHA-256 of the archived text
28243495975db6cdd91d9cbe0b94b398b659db64e66cac83d2510371d924f210
Stable URL of this page
https://metraipolis.com/documento/dc_aff86af1d84f

How to cite

Rituximab monotherapy versus glucocorticoid therapy for adult minimal change disease: a retrospective study on noninferiority — Europe PMC PMID:41446027 — Europe PMC (en), https://europepmc.org/article/MED/41446027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aff86af1d84f (Metraipolis archive dc_aff86af1d84f, sha256 28243495975db6cdd91d9cbe0b94b398b659db64e66cac83d2510371d924f210)
BibTeX
@misc{dcaff86af1d84f,
  title = {Rituximab monotherapy versus glucocorticoid therapy for adult minimal change disease: a retrospective study on noninferiority — Europe PMC PMID:41446027},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41446027},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aff86af1d84f; sha256 28243495975db6cdd91d9cbe0b94b398b659db64e66cac83d2510371d924f210},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41446027. Agents can read the archived copy with the MCP tool read_document.